Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution
Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
03/1999
03/30/1999US5888248 Dermal-epidermal in vitro test system
03/30/1999CA2249058A1 Biologically tolerated low molecular weight polyethylenimines
03/25/1999WO1999014326A1 Mage-3 peptides presented by hla class ii molecules
03/25/1999WO1999014230A1 Mammaglobin, a secreted mammary-specific breast cancer protein
03/25/1999WO1999013904A1 T-cell vaccination for the treatment of multiple sclerosis
03/25/1999WO1999013891A1 Therapeutic preparation comprising shark cartilage
03/25/1999WO1999013890A1 Treatment of stress and preconditioning against stress
03/25/1999WO1999013868A1 Methods for treating ocular diseases
03/25/1999WO1999013726A1 Neuronal cells and an immunosuppressant and anti-inflammatory factor
03/25/1999WO1998049268A9 Natural killer cell lines and methods of use
03/25/1999WO1998048027A3 Materials and methods for treatment of retinal diseases
03/25/1999WO1998048009A3 Materials and methods for ribozyme treatment of retinal diseases
03/25/1999CA2304373A1 T-cell vaccination for the treatment of multiple sclerosis
03/25/1999CA2304167A1 Mammaglobin, a secreted mammary-specific breast cancer protein
03/25/1999CA2303069A1 Treatment of stress and preconditioning against stress
03/25/1999CA2244971A1 Mure
03/24/1999CN1212013A Method of purifying thrombin-like protease enzymes obtained from snake venom
03/24/1999CN1212004A Inorganic pigment microparticles covered with chitin layer
03/24/1999CN1211924A Immunomodulatory complex for helicobacter bacteria
03/24/1999CN1211449A Neospora veccine
03/24/1999CN1211444A Chinese medicinal powder preparation for treating hepatocirrhosis
03/24/1999CN1211442A Medicated plaster for treating lumbago
03/24/1999CN1211433A Capsule for removing blood stasis and activating blood flow
03/24/1999CN1211432A Anticancer oral liquid and its preparation method
03/24/1999CN1211423A Fe-Ca nutrient combination and its preparation method
03/24/1999CN1211422A Prescription for treating hepatitis and tuberculosis
03/24/1999CN1042597C Process for producing vision-brighting and blood sugar decreasing composition
03/23/1999US5886145 Isolated nucleic acid molecules, peptides which form complexes with MHC molecule HLA-A2 and uses thereof
03/23/1999US5886038 Topically administering to a human a composition having isopropyl myristate as the only active ingredient
03/23/1999US5885832 Human lens epithelial cell line
03/23/1999US5885829 Growing viable oral tissue cells on a synthetic matrix in vitro under conditions effective and for a period of time sufficient to allow proliferation of viable oral tissue cells
03/23/1999US5885808 Genetically modifying adenovirus or adenovirus like particle to produce a binding site which is incorporated as a fusion protein with fiber protein, infecting cells with above viruses, culturing and harvesting
03/23/1999US5885795 Methods of expressing angiostatic protein
03/23/1999US5885619 Large area submucosal tissue graft constructs and method for making the same
03/23/1999US5885588 Schizophrenia associated with an autoimmune reaction initiated by an infection can be treated by injection comprising dead cell of mycobacterium vaccae
03/23/1999US5885572 Administering polypeptide or active fragment to treat bacterial infections
03/23/1999US5885570 Induction of tolerance with modified immunogens
03/23/1999CA2093513C Methods and compositions for suppressing allograft rejection in mammals
03/22/1999CA2244239A1 Novel era
03/18/1999WO1999013095A2 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses
03/18/1999WO1999013073A2 Viral vector system capable of expressing an apoptosis-associated gene
03/18/1999WO1999013064A2 Viral infection of cells using viral vectors
03/18/1999WO1999013054A2 Method for the treatment or diagnosis of human pathologies with disseminated or difficult to access cells or tissues
03/18/1999WO1999013053A1 Genetically modified tumor-targeted bacteria with reduced virulence
03/18/1999WO1999012584A1 Methods for inhibiting rejection of transplanted tissues by bone grafting
03/18/1999WO1999012574A1 Improvements in or relating to expression of immunogenic substances
03/18/1999WO1999012573A1 Improvements in or relating to regulation of t cell activation
03/18/1999WO1999012555A1 Galactosidase modified submucosal tissue
03/18/1999WO1999012533A1 A method of modulating cellular activity
03/18/1999WO1998059035A3 Serum-free cell growth medium
03/18/1999WO1998057672A3 Process for reducing the concentration of viral and molecular pathogens in a biological material
03/18/1999WO1998052619A3 Peptide-coated implants and methods for producing same
03/18/1999DE19740571C1 Antigen-specific stimulation of T cells
03/18/1999DE19740357A1 New sugar phosphate compounds
03/18/1999CA2303618A1 Improvements in or relating to expression of immunogenic substances
03/18/1999CA2303617A1 Improvements in or relating to regulation of t cell activation
03/18/1999CA2303396A1 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses
03/18/1999CA2303008A1 Methods for inhibiting rejection of transplanted tissues by bone grafting
03/18/1999CA2300387A1 Method for the treatment or diagnosis of human pathologies with disseminated or difficult to access cells or tissues
03/17/1999EP0902086A1 Tuberculosis vaccine
03/17/1999EP0901521A1 Antigenic modulation of cells
03/17/1999EP0901405A1 Fibrinogen apparatus, method and container
03/17/1999EP0901371A1 Alteration of microbial populations in the gastrointestinal tract
03/17/1999EP0604590B1 Gas plasma treated porous medium and method of separation using same
03/17/1999CN1211279A Composition and methods for the treatment and diagnosis of breast cancer
03/17/1999CN1211277A Systems and methods for removing viral agents from blood
03/17/1999CN1211189A Urogenital and intestinal disorder compositions comprising a substrance derived from plant species of the ericaceae family and a lactic acid bacteria growth factor
03/17/1999CN1211188A Urogenital and intestinal compositions
03/17/1999CN1210727A Chinese drugs for curing male sexual dys-function and its preparing technology
03/17/1999CN1210721A Medicine for burn and its preparing process
03/17/1999CN1210720A Hernia roll
03/17/1999CN1210719A Nutritive health products of wood frog oil
03/17/1999CN1210718A Method for preparing leukocytic extract as immunopotentiator
03/17/1999CN1042493C Process for preparation of human placental thymosin
03/16/1999US5883231 Artificial menses fluid
03/16/1999US5883137 Compositions and methods for the control of smoking
03/16/1999US5882929 Biopolymer tissues for prosthesis
03/16/1999US5882912 Retrovirus isolated from humans
03/16/1999US5882896 M protein
03/16/1999US5882643 Identification and characterization of such factors which can play a role in preventing, ameliorating or correcting infections, dysfunctions or diseases. a novel lep gene of streptococcus pneumoniae.
03/16/1999CA2090186C Method of treatment of hiv-seropositive individuals with dietary whey proteins
03/12/1999WO1998009637A2 Treatment of diabetes
03/12/1999CA2264774A1 Treatment of diabetes
03/12/1999CA2218625A1 Stress treatment and preconditioning against stress
03/11/1999WO1999011759A1 GLUCOSE RESPONSIVE β-CELL LINE
03/11/1999WO1999011758A2 Cultures of human cns neural stem cells
03/11/1999WO1999011664A1 Genetically engineered cells which express bone morphogenetic proteins
03/11/1999WO1999011220A1 Transplants coated with autologous endothelial cells
03/11/1999WO1998049300A3 Truncated vegf-related proteins
03/11/1999DE19738903A1 Therapeutic containing mineral, plant material and animal material
03/11/1999CA2302830A1 Glucose responsive .beta.-cell line
03/11/1999CA2302484A1 Cultures of human cns neural stem cells
03/11/1999CA2301882A1 Genetically engineered cells which express bone morphogenetic proteins
03/10/1999EP0900849A1 Receptor-mediated gene transfer system for targeting tumor gene therapy
03/10/1999EP0900848A2 MecB polynucleotides and polypeptides from the Clpc ATPase family of Stapyloccoccus aureus
03/10/1999EP0900845A2 Signal recognition particle polypeptides and polynucleotides
03/10/1999EP0900231A1 Flea protease proteins, nucleic acid molecules, and uses thereof
03/10/1999EP0900089A1 Biological material free of viral and molecular pathogens and a process for the production thereof
03/10/1999EP0773951B1 Dinucleoside-5',5'-pyrophosphates
03/10/1999CN1210558A Recombinant phages
1 ... 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 1109 1110 1111 1112 1113 1114 ... 1259